Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase.

Rana, Sandeep; Mallareddy, Jayapal Reddy; Singh, Sarbjit; Boghean, Lidia; Natarajan, Amarnath

Rana, Sandeep; Mallareddy, Jayapal Reddy; Singh, Sarbjit; Boghean, Lidia; Natarajan, Amarnath.

Afiliación

Rana S; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA.
Mallareddy JR; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Singh S; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Boghean L; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Natarajan A; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Cancers (Basel) ; 13(21)2021 Nov 02.

Article en En | MEDLINE | ID: mdl-34771669

Palabras clave

CDK; PROTAC; cancer; kinase; molecular glue

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google